To include your compound in the COVID-19 Resource Center, submit it here.

PDL BioPharma, Roche cancer, ophthalmic, inflammation news

The Second Judicial District Court of Nevada denied motions to dismiss claims against PDL by Roche and its Genentech Inc. unit in

Read the full 221 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE